SCOLARI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 24.427
EU - Europa 17.577
AS - Asia 14.371
SA - Sud America 3.171
Continente sconosciuto - Info sul continente non disponibili 586
AF - Africa 505
OC - Oceania 88
Totale 60.725
Nazione #
US - Stati Uniti d'America 23.931
PL - Polonia 5.849
CN - Cina 4.736
SG - Singapore 4.417
UA - Ucraina 3.595
BR - Brasile 2.660
IT - Italia 2.640
HK - Hong Kong 2.057
DE - Germania 1.432
FI - Finlandia 1.141
VN - Vietnam 1.090
FR - Francia 781
TR - Turchia 583
GB - Regno Unito 557
IE - Irlanda 495
RU - Federazione Russa 478
BD - Bangladesh 279
IN - India 275
CA - Canada 249
NG - Nigeria 241
JP - Giappone 212
AR - Argentina 205
NL - Olanda 173
ID - Indonesia 168
MX - Messico 136
IQ - Iraq 109
SE - Svezia 93
AU - Australia 86
EC - Ecuador 79
ZA - Sudafrica 74
CO - Colombia 66
ES - Italia 57
PK - Pakistan 54
SA - Arabia Saudita 48
AT - Austria 47
MA - Marocco 47
PY - Paraguay 43
CZ - Repubblica Ceca 42
VE - Venezuela 37
UZ - Uzbekistan 35
MY - Malesia 34
BE - Belgio 31
EG - Egitto 29
CL - Cile 28
JO - Giordania 26
PE - Perù 26
EU - Europa 25
KE - Kenya 24
IR - Iran 23
TW - Taiwan 22
CH - Svizzera 21
KZ - Kazakistan 19
TN - Tunisia 19
CR - Costa Rica 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 17
KR - Corea 17
LT - Lituania 17
NP - Nepal 17
AL - Albania 16
JM - Giamaica 15
UY - Uruguay 15
DZ - Algeria 14
IL - Israele 14
PH - Filippine 14
LV - Lettonia 13
PA - Panama 13
PS - Palestinian Territory 13
ET - Etiopia 12
HN - Honduras 12
KG - Kirghizistan 12
RO - Romania 12
TH - Thailandia 12
PT - Portogallo 11
RS - Serbia 11
TT - Trinidad e Tobago 11
BO - Bolivia 10
DO - Repubblica Dominicana 9
BG - Bulgaria 8
GR - Grecia 8
GT - Guatemala 8
LB - Libano 8
MU - Mauritius 8
AM - Armenia 7
BB - Barbados 7
HU - Ungheria 7
OM - Oman 7
MK - Macedonia 6
SC - Seychelles 6
SN - Senegal 6
SV - El Salvador 6
BY - Bielorussia 5
DK - Danimarca 5
HR - Croazia 5
NO - Norvegia 5
BW - Botswana 4
CG - Congo 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
Totale 60.098
Città #
Warsaw 5.826
Jacksonville 2.279
Singapore 2.249
Hong Kong 2.019
Fairfield 2.014
Woodbridge 1.999
Ashburn 1.720
Houston 1.193
San Jose 1.145
Princeton 971
The Dalles 951
Ann Arbor 928
Cambridge 879
Beijing 829
Wilmington 772
Seattle 760
Nanjing 740
Helsinki 661
Council Bluffs 649
Dublin 490
Columbus 462
Istanbul 460
Lauterbourg 431
Los Angeles 428
New York 404
Chandler 402
Milan 332
Ho Chi Minh City 324
Nanchang 296
Des Moines 240
Abuja 238
Buffalo 221
São Paulo 219
Dong Ket 216
Moscow 200
Changsha 185
Redondo Beach 185
Shenyang 178
Hebei 176
Brescia 173
Hanoi 158
Santa Clara 156
Dallas 153
Chicago 137
Munich 131
Dearborn 127
Phoenix 124
San Diego 122
Memphis 121
Tianjin 116
Shanghai 115
Rome 114
Jiaxing 110
San Francisco 101
Hangzhou 100
Franklin 97
Rio de Janeiro 97
Jinan 90
Tokyo 88
Orem 84
Verona 79
Toronto 78
Jakarta 77
London 67
Nuremberg 67
Kocaeli 60
Brooklyn 58
Kunming 57
Montreal 57
Atlanta 56
Guangzhou 53
Belo Horizonte 47
Chennai 46
Boston 41
Lanzhou 41
Baghdad 40
Brasília 40
Curitiba 39
Frankfurt am Main 39
Bologna 38
Ningbo 38
Paris 38
Zhengzhou 36
Turku 35
Denver 34
Melbourne 34
Porto Alegre 34
Redwood City 34
Springfield 33
Amsterdam 31
Campinas 31
Dhaka 31
Mumbai 31
Palermo 31
Washington 31
Brno 30
Naples 30
Norwalk 30
Tashkent 30
Haiphong 29
Totale 38.916
Nome #
The pathophysiology of IgA nephropathy 1.017
Trattamento del linfocele postoperatorio mediante instillazione su guida ecografica di polivinil-pirrolidone iodico. Casistica personale. 899
Genome-wide association study identifies susceptibility loci for IgA nephropathy 538
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 500
The copy number variation landscape of congenital anomalies of the kidney and urinary tract. 311
Suprarenal aortic cross-clamping in the elective surgery of abdominal aortic aneurysms. Lessons from 68 cases out of consecutive survey of 746 abdominal aortic substitutions. 304
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 302
Genetic drivers of kidney defects in the digeorge syndrome 295
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway 295
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 281
Insufficienza renale acuta e o subacuta richiedente dialisi in corso di malattia ateroembolica renale: impatto sulla sopravvivenza del paziente e del rene. 276
Mutations in DSTYK and dominant urinary tract malformations. 273
The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. 271
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. 267
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 266
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 266
Defective intracellular trafficking of uromodulin mutant isoforms 261
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin 259
PREDICTORS OF RENAL AND PATIENT OUTCOMES IN ATHEROEMBOLIC RENAL DISEASE: A PROSPECTIVE STUDY. 259
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis 256
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 256
Atheroembolic renal disease 256
Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. 256
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. 256
Lack of association between dialysis modality and outcomes in atheroembolic renal disease 253
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases 252
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study 251
CHOLESTEROL CRYSTAL EMBOLISM: A RECOGNIZABLE CAUSE OF RENAL DISEASE 250
Uromodulin storage diseases: clinical aspects and mechanisms. 249
The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. 249
IgA nephropathy: the presence of familial disease does not confer an increased risk for progression 247
Malattia cistica della midollare (MCKD), Nefropatia iperuricemica familiare giovanile (FJHN) e Glomerulocisti (GCKD) sono causate da mutazioni dello stesso gene (UMOD) che determinano alterazioni del trasporto cellulare di uromodulina. 247
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. 245
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. 244
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. 241
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. 241
Urinary secretion and extracellular aggregation of mutant uromodulin isoforms 240
Autosomal Dominant tubulointerstitial Kidney Disease with Adult onset due to a novel Renin Mutation Mapping in the Mature protein 240
Genetic studies of IgA nephropathy: past, present, and future. 233
IgA nephropathy--the case for a genetic basis becomes stronger. 233
Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds 232
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families 232
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. 231
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. 228
Coexistence of Different Circulating Anti-PodocyteAntibodies in Membranous Nephropathy 227
Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. 226
Copy number disorders are a Common Cause of Congenital Kidney Malformations 224
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis 223
Genetic approaches to human renal agenesis/hypoplasia and dysplasia. 222
Phenotypic expansion of DGKE-associated diseases. 222
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3 221
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 221
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. 220
The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. 210
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
The progression from obesity to type 2 diabetes in Alström syndrome. 205
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 200
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 199
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 198
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 198
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 198
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. 197
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans 195
Uromodulin: from monogenic to multifactorial diseases. 192
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 191
Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. 190
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model 190
IDENTIFICATION OF A NEW LOCUS FOR MEDULLARY CYSTIC DISEASE ON CHROMOSOME 16 181
Berger's Disease 180
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 178
LES FORMES FAMILIALES DE NÉPHROPATHIE À IgA ÉTUDES CLINIQUE ET GÉNÉTIQUE 177
ORO-FACIO-DIGITAL SYNDROME 176
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 176
AUTOSOMAL DOMINANT MEDULLARY CYSTIC KIDNEY DISEASE 174
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. 162
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 162
The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors 160
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 158
Non-collagen genes role in digenic Alport syndrome 156
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 155
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 154
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees. 154
Ciclosporin in renal transplantation: identification of two populations with different drug metabolism. 153
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 150
[The role of magnetic resonance angiography in the assessment of arterial stenosis in the transplanted kidney] 150
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait 148
Immunogenetics of Henoch-Schoenlein disease. 148
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 147
Early histopathologic changes predicting long-term kidney transplant survival. 147
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. 147
Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. 147
Clustering familiare di differenti forme di glomerulonefrite primitiva: studio Valtrompia: 147
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. 146
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 146
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 145
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 144
32 casi di glomerulonefrite primitiva a carattere familiare: esiste un ruolo dell'HLA? 144
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? 141
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 141
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 141
Totale 23.170
Categoria #
all - tutte 270.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.215 0 0 27 101 55 94 171 202 172 339 284 770
2022/20231.966 518 20 32 102 118 644 6 146 193 17 89 81
2023/20242.787 104 49 153 244 77 274 122 80 1.022 45 63 554
2024/20257.332 48 46 53 839 965 576 996 200 721 386 1.588 914
2025/202616.401 1.275 2.311 1.457 2.628 1.215 980 2.517 709 1.069 1.233 724 283
2026/20272.714 987 770 957 0 0 0 0 0 0 0 0 0
Totale 60.725